ICYMI, this week we had stories on physician assistants, diverse perspectives in aesthetic medicine, and more.
This week's edition of the Mainstream Patients features stories about the difference between a sun burn and sun poisoning, micro-coring, and more.
A physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment. One way to ensure that a practice maximizes its coding regimen is to make sure each session can be efficiently billed.
Take a look back at our most popular news from March 2022.
Renata Block, MMS, PA-C, president of the Society of Dermatology Physician Assistants (PAs) talked with Dermatology Times® at the American Academy of Dermatology 2022 Annual Meeting about the broadening opportunities for these advanced health care providers to help fill the demand gap for treatment of skin and hair disorders as well as aesthetic services.
What are the best post- and pre-lightening products and strategies for optimal results on all skin types? Renata Block, president of the Society of Dermatology Physician Assistants, walked through her pearls in this interview at the American Academy of Dermatology 2022 Annual Meeting.
More Americans “priced out of the system,” survey finds.
Nearly 1 in 10 adults owe at least $250 for health care costs.
In this week’s Pointers with Dr Portela, the 208SkinDoc attended the 2022 American Academy of Dermatology (AAD) Annual Meeting and talked to several dermatologists about skin care and common misconceptions about this topic.
Terri Phillips, MD, FAAP, expands on her letter to the editor in the April issue of Dermatology Times® diving into how her experience has shaped the her view of the aesthetics industry, the challenges both physicians and patients face, and more.
Government help needed ‘to ensure the health of the American public.’
A new study suggests it doesn’t, at least for the short term.
Patients’ ability to choose can affect your practice.
Wastage data published for first two months of 2021.
Nearly all survey takers reported wanting topical treatment options that are more effective, not steroids, and simpler to use.
LEO Pharma presented long-term data from an interim analysis of its ECZTEND 5-year extension trial, showing no new safety signals.
The company reported positive results from the PEARL-1 clinical phase 1 study regarding KB301 as an investigational gene-based treatment to address the underlying biology of aging skin.
The results from the Evelo Biosciences EDP1815 treatment provide the first demonstration in a phase 2 trial of the safety and efficacy of an orally-administered, gut-restricted SINTAX medicine.
Study examines wealth, but smoking matters more to longevity after age 65.